Synopsys (SNPS) and Samsung Foundry Team Up to Advance AI Chip Design

Synopsys Inc. (NASDAQ:SNPS) is one of the 11 must-buy AI stocks analysts are betting on. On June 16, the company announced a strategic collaboration with Samsung Foundry. The two are joining forces to power the next generation of chip designs capable of handling edge artificial intelligence, high-performance computing, and artificial intelligence applications.

Synopsys (SNPS) and Samsung Foundry Team Up to Advance AI Chip Design

A close-up of a complex network of integrated circuits used in logic semiconductors.

The companies are to power the most complex multi-designs that enable customers to deliver advanced technologies to the market. They have already achieved a successful customer tape from an HBM3 design on the Samsung SF2 process and I-cube technology.

Synopsys has also achieved certification for its AI-driven digital and analog flows in Samsung SF2 processes. The milestone allows the company to accelerate the development of high-performance designs. Additionally, the company has expanded its IP portfolio to support the development of applications for high-performance computing in the automotive markets.

Synopsys Inc. (NASDAQ:SNPS) delivers electronic design automation (EDA) software and IP solutions for designing and testing integrated circuits. Operating through Design Automation and Design IP segments, it offers tools for digital and custom IC design, verification, FPGA design, TCAD, and AI-driven solutions. Its IP portfolio includes interfaces like USB, PCIe, Ethernet, and HDMI, as well as processor cores, embedded memories, security, automotive, and SoC infrastructure components.

While we acknowledge the potential of SNPS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Healthcare Stocks to Buy Now and 10 Stocks Analysts Are Upgrading Today.

Disclosure: None.